File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/0090-8258(90)90417-J
- Scopus: eid_2-s2.0-0025119677
- PMID: 2227584
- WOS: WOS:A1990EH62200005
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Etoposide combination chemotherapy in refractory ovarian malignant germ cell tumor
Title | Etoposide combination chemotherapy in refractory ovarian malignant germ cell tumor |
---|---|
Authors | |
Issue Date | 1990 |
Publisher | Academic Press. The Journal's web site is located at http://www.elsevier.com/locate/ygyno |
Citation | Gynecologic Oncology, 1990, v. 39 n. 2, p. 123-126 How to Cite? |
Abstract | Thirty-three patients with malignant germ cell tumor of the ovary received postoperative vincristine, dactinomycin, and cyclosphosphamide (VAC) treatment. Eight failed VAC treatment and received etoposide, bleomycin, and cisplatin (PEB) combination chemotherapy. Three were cured and remained disease free 24-79 months after completion of PEB therapy. |
Persistent Identifier | http://hdl.handle.net/10722/147856 |
ISSN | 2023 Impact Factor: 4.5 2023 SCImago Journal Rankings: 1.627 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Wong, LC | en_HK |
dc.contributor.author | Collins, RJ | en_HK |
dc.contributor.author | Ngan, HYS | en_HK |
dc.contributor.author | Ma, HK | en_HK |
dc.date.accessioned | 2012-05-29T06:09:35Z | - |
dc.date.available | 2012-05-29T06:09:35Z | - |
dc.date.issued | 1990 | en_HK |
dc.identifier.citation | Gynecologic Oncology, 1990, v. 39 n. 2, p. 123-126 | en_HK |
dc.identifier.issn | 0090-8258 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/147856 | - |
dc.description.abstract | Thirty-three patients with malignant germ cell tumor of the ovary received postoperative vincristine, dactinomycin, and cyclosphosphamide (VAC) treatment. Eight failed VAC treatment and received etoposide, bleomycin, and cisplatin (PEB) combination chemotherapy. Three were cured and remained disease free 24-79 months after completion of PEB therapy. | en_HK |
dc.language | eng | en_US |
dc.publisher | Academic Press. The Journal's web site is located at http://www.elsevier.com/locate/ygyno | en_HK |
dc.relation.ispartof | Gynecologic Oncology | en_HK |
dc.subject.mesh | Carboplatin - Pharmacology | en_US |
dc.subject.mesh | Cell Division - Drug Effects | en_US |
dc.subject.mesh | Cell Line | en_US |
dc.subject.mesh | Cell Survival - Drug Effects | en_US |
dc.subject.mesh | Cisplatin - Pharmacology | en_US |
dc.subject.mesh | Drug Screening Assays, Antitumor | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Ovarian Neoplasms | en_US |
dc.title | Etoposide combination chemotherapy in refractory ovarian malignant germ cell tumor | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Collins, RJ:rcollins@hkucc.hku.hk | en_HK |
dc.identifier.email | Ngan, HYS:hysngan@hkucc.hku.hk | en_HK |
dc.identifier.authority | Collins, RJ=rp00251 | en_HK |
dc.identifier.authority | Ngan, HYS=rp00346 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1016/0090-8258(90)90417-J | en_HK |
dc.identifier.pmid | 2227584 | - |
dc.identifier.scopus | eid_2-s2.0-0025119677 | en_HK |
dc.identifier.volume | 39 | en_HK |
dc.identifier.issue | 2 | en_HK |
dc.identifier.spage | 123 | en_HK |
dc.identifier.epage | 126 | en_HK |
dc.identifier.isi | WOS:A1990EH62200005 | - |
dc.publisher.place | United States | en_HK |
dc.identifier.scopusauthorid | Wong, LC=7402092003 | en_HK |
dc.identifier.scopusauthorid | Collins, RJ=7403350455 | en_HK |
dc.identifier.scopusauthorid | Ngan, HYS=34571944100 | en_HK |
dc.identifier.scopusauthorid | Ma, HK=7403095603 | en_HK |
dc.identifier.issnl | 0090-8258 | - |